[247] In April 2025, Eli Lilly, represented by Kirkland & Ellis and Walsh Pizzi O'Reilly Falanga, filed a series of lawsuits in federal courts in New Jersey and California against several telehealth and compounding pharmacy companies, including Willow Health Services, Henry Meds, Mochi Health, Fella Health, and Empower Clinic Services, alleging unfair competition, false advertising, and deceptive business practices related to the sale of unapproved compounded tirzepatide products marketed for weight loss
Heres why when you stop tirzepatide matters for anesthesia, how recommendations have changed, and which people may need additional precautions
Through this two-step endocrine cascade, CJC-1295 indirectly influences tissue adaptation and recovery-related signaling
What is the Precision Peptide Genetic Test and how does it help with hormone balance
Effect of ezogabine on cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis: a randomized clinical trial
